We are live on ! Find out more
TCON

TRACON Pharmaceuticals, Inc. Common Stock
TCON

Delisted

TCON was delisted on the 27th of June, 2024.

Back to rankings

Fund managers haven’t disclosed any holdings of TCON yet.

TCON Hedge Fund Activity: Q4 2024 in Review

0 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in TRACON Pharmaceuticals, Inc. Common Stock (TCON) for Q4 2024, worth a combined $0 — down 100% from $5 a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of TCON and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

The largest seller was Game Plan Financial Advisors, exiting entirely with an estimated $5 sold.

  • 0 institutional investors held TRACON Pharmaceuticals, Inc. Common Stock (TCON) as of Q4 2024, down from 1 in Q3 2024.
  • Funds reported $0 of TRACON Pharmaceuticals, Inc. Common Stock stock for Q4 2024, down 100% quarter-over-quarter.
  • 0 funds opened new TRACON Pharmaceuticals, Inc. Common Stock positions in Q4 2024 and 1 closed out, a net change of -1 holder.
  • The largest TRACON Pharmaceuticals, Inc. Common Stock seller in Q4 2024 was Game Plan Financial Advisors, an estimated $5 sold.

Based on aggregated 13F filings for Q4 2024.